These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7594731)

  • 41. Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
    Földi R; Szilágyi J; Kardos G; Berényi R; Kovács R; Majoros L
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):338-42. PubMed ID: 22726529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of fluconazole effect on Candida albicans viability during extended incubations.
    Sohnle PG; Hahn BL; Fassel TA; Kushnaryov VM
    Med Mycol; 1998 Feb; 36(1):29-36. PubMed ID: 9776809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid identification of fluconazole resistance using Chrom agar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; Johni ES
    Indian J Pathol Microbiol; 2001 Jul; 44(3):305-7. PubMed ID: 12024918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
    Wang JL; Chang SC; Hsueh PR; Chen YC
    J Microbiol Immunol Infect; 2004 Aug; 37(4):236-41. PubMed ID: 15340652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile.
    Neufeld PM; Melhem Mde S; Szeszs MW; Ribeiro MD; Amorim Ede L; da Silva M; Lazéra Mdos S
    Braz J Microbiol; 2015 Jun; 46(2):477-84. PubMed ID: 26273262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of voriconazole against Candida species isolated in Taiwan.
    Yang YL; Cheng HH; Lo HJ
    Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages.
    Maródi L; Korchak HM; Johnston RB
    J Immunol; 1991 Apr; 146(8):2783-9. PubMed ID: 1901885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years.
    Chen YC; Chang SC; Luh KT; Hsieh WC
    J Antimicrob Chemother; 2003 Jul; 52(1):71-7. PubMed ID: 12775680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
    Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of Candida albicans, macrophages and fluconazole: in vitro and ex vivo observations.
    Tullio V; Cuffini AM; De Leo C; Perrone F; Carlone NA
    J Chemother; 1996 Dec; 8(6):438-44. PubMed ID: 8981184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antifungal Activity, Gas Chromatographic-Mass Spectrometric Analysis And in silico Study of Punica Granatum Peel Extracts Against Fluconazole Resistant Strains of Candida Species.
    Paul S; Mohanram K; Kannan I
    Curr Pharm Biotechnol; 2018; 19(3):250-257. PubMed ID: 29766800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
    Linares MJ; Charriel G; Solís F; Casal M
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species.
    Lupetti A; Paulusma-Annema A; Welling MM; Dogterom-Ballering H; Brouwer CP; Senesi S; Van Dissel JT; Nibbering PH
    Antimicrob Agents Chemother; 2003 Jan; 47(1):262-7. PubMed ID: 12499200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
    Yoo JI; Choi CW; Lee KM; Kim YK; Kim TU; Kim EC; Joo SI; Yun SH; Lee YS; Kim BS
    Med Mycol; 2009; 47(5):554-8. PubMed ID: 18819023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
    Tan GL; Peterson EM
    J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of the role of iron in the anticryptococcal activity of human serum and fluconazole.
    Grover DD; Brummer E; Stevens DA
    Mycopathologia; 1996; 133(2):71-7. PubMed ID: 8751825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.
    Brummer E; Bhagavathula PR; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2487-92. PubMed ID: 1336949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.